Article
GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system.
Cell transplantation - 1 Jan 2013
Rojewski Markus T, Fekete Natalie, Baila Stefano, Nguyen Kim, Fürst Daniel, Antwiler Delbert, Dausend Julia, Kreja Ludwika, Ignatius Anita, Sensebé Luc, Schrezenmeier Hubert
Abstract excerpt
The estimated frequency of MSCs in BM is about 0.001-0.01% of total nucleated cells. Most commonly, one applied therapeutic cell dose is about 1-5 million MSCs/kg body weight, necessitating a reliable, fast, and safe expansion system. The limited availability of MSCs demands for an extensive ex vivo amplification step to accumulate sufficient cell numbers. Human platelet lysate (PL) has proven to be a safe and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
